Vaudit, formerly BlokID, today announced the successful closing of a $7.3 million seed round of financing led by Mucker Capital, with participation from AVV, AppWorks, Plug and Play, and Kyber Knight. The list of investors notably includes Mucker Capital’s Omar Hamoui who founded AdMob, a mobile ad platform acquired by Google for $750 million, and AVV’s Binh Tran who co-founded Klout, a social media analytics company acquired by Lithium Technologies for $200 million. Following a pre-seed raise of $1.25 million, Vaudit has raised a total of $8.5 million.
Vaudit is a real-time AI audit engine that monitors advertising campaigns 24/7, detects billing anomalies, and generates legally defensible audit evidence to help businesses recover wasted ad spend. With advertisers increasingly under pressure to justify budgets and maximize efficiency, Vaudit delivers the tools to surface overcharges, flag waste, and push for platform refunds, with documentation that stands up to internal finance and legal review. VPN Ranks notes ad fraud losses totaled $28.6 billion in the U.S. alone last year.
Read More – Reka Raises $110M in Funding
The company supports 1,000+ customers worldwide and has audited more than 558 million advertising events. Since launching late last year, Vaudit is now auditing over $150 million in annualized ad spend, and in some cases recording up to 30% in monthly overcharges for customers when reconciling against the traffic they were actually billed for. Vaudit services channel partners who are looking to enhance their value proposition for clients regularly running ad campaigns, as well as leading consumer and enterprise brands such as Accenture, HP, Huawei, Husqvarna, Marmot, Panasonic, RE/MAX, SAP and Volkswagen.
“We’re excited to partner with adtech veterans like Omar and Binh to pioneer a new standard in digital advertising accountability,” said Michael Hahn, Founder and CEO of Vaudit. “The online advertising industry has normalized waste and fraud for far too long, with clicks that don’t track, campaigns that overspend, and billing that goes unverified.”
Read More – Dash Bio Secures $11M to Accelerate a New Era in Bioanalysis
